Skip to content

Stanford Medicine Scientists have devised a blood test to predict some cancer relapses after patients have already been treated.

Stanford Medicine Scientists have devised a blood test to predict some cancer relapses after patients have already been treated.

Published on

A new way to deliver mRNA as a COVID-19 vaccine may avoid side effects and increase customization to prevent infection.

A new way to deliver mRNA as a COVID-19 vaccine may avoid side effects and increase customization to prevent infection.

'Resting' exhausted cancer-fighting immune cells enhances their tumor-killing activity, which may help people with blood and solid cancers.

'Resting' exhausted cancer-fighting immune cells enhances their tumor-killing activity, which may help people with blood and solid cancers.

A Stanford-developed anti-cancer therapy currently in clinical trials may also reduce vascular inflammation in heart disease.

A Stanford-developed anti-cancer therapy currently in clinical trials may also reduce vascular inflammation in heart disease.

Published on

Pioneering immunotherapy drug Provenge is enjoying a revival, thanks to a large new clinical trial that will test it in men with early prostate cancer.

Pioneering immunotherapy drug Provenge is enjoying a revival, thanks to a large new clinical trial that will test it in men with early prostate cancer.

Scientists have made an important step forward in treating a deadly childhood brain tumor, using T cells engineered to target a surface sugar found on the cancer cells.

Scientists have made an important step forward in treating a deadly childhood brain tumor, using T cells engineered to target a surface sugar found on the cancer cells.